Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (321-330 of 427) with videos related to

Pageof 43
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Internal Medicine Journal|September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Christine Semira, Hui-Li Wong, Kathryn Field, et al.
European Radiology|August 31, 2019
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRINatsuko Onishi, Meredith Sadinski, Peter Gibbs, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 29, 2022
Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older IndividualsAndrew Bakshi, Yin Cao, Suzanne G Orchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerRobert N Jorissen, Peter Gibbs, Michael Christie, et al.
Plos One|March 21, 2015
Blood-based protein biomarker panel for the detection of colorectal cancerKim Y C Fung, Bruce Tabor, Michael J Buckley, et al.
BJU International|November 13, 2022
Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancerRichard Kelly, Andrew Jensen, Nathasha Karunaratna, et al.
Cancer Immunity|July 17, 2003
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanomaJonathan Cebon, Elke Jäger, Mark J Shackleton, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 24, 2022
Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic CohortsJonathan M Downie, Moeen Riaz, Jing Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancersRobert N Jorissen, Lara Lipton, Peter Gibbs, et al.
Pageof 43

Showing results (321-330 of 427) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Internal Medicine Journal|September 20, 2018
Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Christine Semira, Hui-Li Wong, Kathryn Field, et al.
European Radiology|August 31, 2019
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRINatsuko Onishi, Meredith Sadinski, Peter Gibbs, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 29, 2022
Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older IndividualsAndrew Bakshi, Yin Cao, Suzanne G Orchard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerRobert N Jorissen, Peter Gibbs, Michael Christie, et al.
Plos One|March 21, 2015
Blood-based protein biomarker panel for the detection of colorectal cancerKim Y C Fung, Bruce Tabor, Michael J Buckley, et al.
BJU International|November 13, 2022
Prostate-specific membrane antigen positron emission tomography-computed tomography use prior to systemic therapy in metastatic castration-resistant prostate cancerRichard Kelly, Andrew Jensen, Nathasha Karunaratna, et al.
Cancer Immunity|July 17, 2003
Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanomaJonathan Cebon, Elke Jäger, Mark J Shackleton, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 24, 2022
Incident Cancer Risk and Signatures Among Older MUTYH Carriers: Analysis of Population-Based and Genomic CohortsJonathan M Downie, Moeen Riaz, Jing Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancersRobert N Jorissen, Lara Lipton, Peter Gibbs, et al.
Pageof 43